This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n9http://en.wikipedia.org/wiki/The_Queen's_Award_for_Enterprise:_International_Trade_(Export)_(2001)
n23http://caligraph.org/resource/Stephen_Carter_(architect)
n16http://caligraph.org/resource/David_Lodge_(neuroscientist)
n7http://caligraph.org/ontology/S&
n6http://en.wikipedia.org/wiki/Category:
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n15http://en.wikipedia.org/wiki/Companies_listed_on_the_New_York_Stock_Exchange_(E)
n14http://en.wikipedia.org/wiki/J.
n11http://caligraph.org/resource/K._K.
n17http://en.wikipedia.org/wiki/S&
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://en.wikipedia.org/wiki/List_of_S&
n20http://caligraph.org/resource/Ronald_W.
owlhttp://www.w3.org/2002/07/owl#
n18http://caligraph.org/resource/Stephen_K.
clgohttp://caligraph.org/ontology/
n8http://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
n22http://caligraph.org/resource/President_(corporate_title)
n13http://caligraph.org/resource/Norfolk_House,
dbrhttp://dbpedia.org/resource/
clgrhttp://caligraph.org/resource/
Subject Item
clgr:Dow_AgroSciences
clgo:foundedBy
clgr:Eli_Lilly_and_Company
Subject Item
n13:_Basingstoke
clgo:owner
clgr:Eli_Lilly_and_Company
Subject Item
clgr:Avid_Radiopharmaceuticals
clgo:parentCompany
clgr:Eli_Lilly_and_Company
Subject Item
clgr:Susan_Reutzel-Edens
clgo:institution
clgr:Eli_Lilly_and_Company
Subject Item
n20:_Davis
clgo:award
clgr:Eli_Lilly_and_Company
Subject Item
n18:_Burley
clgo:institution
clgr:Eli_Lilly_and_Company
Subject Item
n16:
clgo:institution
clgr:Eli_Lilly_and_Company
Subject Item
n11:_Chen
clgo:institution
clgr:Eli_Lilly_and_Company
Subject Item
clgr:Jon_Erik_Fyrwald
clgo:board
clgr:Eli_Lilly_and_Company
Subject Item
clgr:Eli_Lilly
clgo:knownFor
clgr:Eli_Lilly_and_Company
Subject Item
clgr:ImClone_Systems
clgo:parentCompany
clgr:Eli_Lilly_and_Company
Subject Item
n23:
clgo:significantBuilding
clgr:Eli_Lilly_and_Company
Subject Item
clgr:Eli_Lilly_and_Company
rdf:type
n7:P_500_company clgo:Pharmaceutical_laboratory clgo:Largest_pharmaceutical_settlement clgo:Orphan_drug_company clgo:Technology_company_established_in_1876 clgo:Manufacturing_company_based_in_Indianapolis clgo:Company_formerly_listed_on_the_Tokyo_Stock_Exchange clgo:Pharmaceutical_company_of_India clgo:Largest_civil_only_pharmaceutical_settlement clgo:Political_action_committee clgo:Biotechnology_company_of_the_United_States clgo:Multinational_company_headquartered_in_the_United_States clgo:Clinical_trial_organization clgo:1876_establishment_in_Indiana clgo:Pharmaceutical_company_established_in_1876 clgo:Biotech_and_pharmaceutical_company_in_the_New_York_metropolitan_area owl:NamedIndividual clgo:Company_listed_on_the_New_York_Stock_Exchange clgo:American_company_established_in_1876
rdfs:label
Eli Lilly and Company
owl:sameAs
dbr:Eli_Lilly_and_Company
prov:wasDerivedFrom
n6:American_companies_established_in_1876 n8:Timeline_of_Indianapolis n8:2019_NASCAR_Xfinity_Series n8:Nifty_Fifty n8:SmithGroup n8:List_of_biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area n8:Alexandria_Real_Estate_Equities n9: n8:MaRS_Discovery_District n8:Pharmaceutical_industry_in_China n8:Cost_of_drug_development n8:July_1980 n8:List_of_largest_biomedical_companies_by_market_capitalization n8:Concordat_on_Openness_on_Animal_Research n8:List_of_political_action_committees n8:List_of_pharmaceutical_companies n8:National_Center_for_Supercomputing_Applications n8:Transatlantic_Business_Council n12:P_500_companies n6:Multinational_companies_headquartered_in_the_United_States n6:Clinical_trial_organizations n6:Pharmaceutical_companies_established_in_1876 n8:Hanshin_Industrial_Region n8:Medication_costs n8:List_of_companies_by_research_and_development_spending n6:Biotechnology_companies_of_the_United_States n8:Pharmaceutical_marketing n8:Great_American_Economic_Revival_Industry_Groups n14:_Walter_Thompson n15: n6:Orphan_drug_companies n6:Companies_formerly_listed_on_the_Tokyo_Stock_Exchange n6:Companies_listed_on_the_New_York_Stock_Exchange n8:List_of_largest_civil_only_pharmaceutical_settlements n8:Pharmaceutical_industry_in_the_United_Kingdom n6:1876_establishments_in_Indiana n6:Pharmaceutical_companies_of_India n8:Program_on_Information_Resources_Policy n17:P_100 n8:Coalition_for_21st_Century_Patent_Reform n6:Manufacturing_companies_based_in_Indianapolis n8:Physio-Control n8:Putnam_Investments n8:List_of_companies_of_the_United_States_by_state n6:Technology_companies_established_in_1876 n8:Pharmaceutical_industry_in_India n8:List_of_largest_pharmaceutical_settlements n8:Pharma_Documentation_Ring n8:Eli_Lilly_and_Company n8:Ethics_in_pharmaceutical_sales n8:List_of_pharmaceutical_laboratories_by_year_of_foundation n8:Pharmaceutical_industry n8:Institute_for_Public_Policy_Research
skos:prefLabel
Eli Lilly and Company
skos:altLabel
Eli Lilly Eli Lilly Discovery Research Laboratories Eli Lilly pharmaceutical company Ely Lilly and Company Lilly Industries Eli Lilly & Company Eli Lilly and Co. Eli Lily & Co Eli Lilly and Company PAC Illegal Marketing of Zyprexa Lilly Diabetes Eli Lilly Holdings Ltd. Eli Lilly's Lilly Pharmaceuticals Eli Lilly and Co. Ltd. Eli Lilly & Company's Lilly Eli Lilly Canada Eli Lilly and Company Scholar Eli Lilly & Co Ely Lilly Eli Lilly UK Eli Lily Eli Lily and Company Lilly Research Laboratories Eli Lilly & Co.
clgo:assets
3.9286E10
clgo:equity
2.699E9
clgo:foundedBy
clgr:Eli_Lilly
clgo:foundingYear
1876
clgo:headquarter
clgr:Indianapolis
clgo:industry
clgr:Chemical_substance clgr:Biotechnology clgr:Health_care clgr:Pharmaceutical_industry clgr:Technology clgr:Medication
clgo:keyPerson
clgr:Chief_executive_officer clgr:Vice_president clgr:Chairperson n22:
clgo:location
clgr:Tokyo clgr:Indianapolis clgr:India clgr:United_States
clgo:netIncome
8.318E9
clgo:numberOfEmployees
33625
clgo:operatingIncome
5.595E9
clgo:owner
clgr:Lilly_Endowment
clgo:owningCompany
clgr:Lilly_Endowment
clgo:product
clgr:Medication
clgo:revenue
2.2319E10
clgo:type
clgr:Public_company